In a murine HSOS model, circulating alanine aminotransferase was significantly reduced after Tβ4 peptide administration.
In plain wordsIn mice with a liver blood-vessel injury model, thymosin β4 lowered the liver enzyme ALT.
- Peptide
- Thymosin beta-4 (human)
- Outcome
- DecreaseCirculating alanine aminotransferase
- Study
mousen: not reported in source
HSOS model- Outcome group
- Liver fat and liver function · Liver
- Studied dose
- Dose not stated
Source sentences
In a murine HSOS model, levels of circulating alanine aminotransferase, aspartate aminotransferase, total bilirubin, and pro-inflammatory cytokines IL-6, IL-1β, and TNF-α were significantly reduced after administration of Tβ4 peptide; furthermore, Tβ4 treatment successfully ameliorated HSEC injury,…